Metatag Title
World Top Pharmaceutical Companies in 2024
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2024, World Largest Pharmaceutical Companies by Market Cap in 2024.
World Top 100 Pharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as pf Jan-05-2024.
McKesson Europe AG is a healthcare company. It is active in 13 countries and works with their partners to provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost effectively. The headquarters is in USA.
As on 2019, it had 1,900 retail pharmacies in five countries and 6,900 partner and brand partner pharmacies.
Bio-pharmaceutical company with headquarters is in Massachusetts, USA.
Hikma Pharmaceuticals is a pharmaceutical company. It develop, manufacture and market nearly 700 quality branded and non branded generic medicines worldwide. The company categories include anti infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. The headquarters is in UK.
HIKMA PHARMACEUTICALS annual revenue was 2,517 million GBP and annual net income was 188 million GBP generated for period year ending Dec-2022.
HIKMA PHARMACEUTICALS annual revenue was 2,553 million GBP and annual net loss was 421 million GBP generated for period year ending Dec-2021.
As on 2022, HIKMA PHARMACEUTICALS had 8800 employees.
RICHTER GEDEON VEGYESZETI GYAR NYILVANOSAN MUKODO is a Specialty Pharmaceutical company focused on therapies across a number of cardiovascular diseases there is an increased demand to osteoporosis and rheumatic diseases. The headquarters is in Hungary.
Bio-pharmaceutical company with headquarters is in California, USA.
Acadia Pharmaceuticals is a Healthcare and Pharmaceutical company. The company is of food and drug administration for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. Around 8 million people in the United States are living with dementia and studies suggest that approximately 30% of people with dementia, 2.4 million people, experience dementia-related hallucinations and delusion. The headquarters is in USA.